|
(P1264)
|
In vivo Implantation of a Functional Tissue Engineered Stentless Pulmonary Valve Using Bone-Marrow-Derived Mesenchymal Stem Cells And Circulating Endothelial Progenitor Cells
|
|
E. M. Delmo Walter, B. Sill, V. Sales, D. Martin, E. Rusk, S. Emani, R. Hetzer, J. Mayer (Boston, Lexington, US; Berlin)
|
|
(P1266)
|
Generation of patient-specific induced pluripotent stem cells from bone marrow-derived mesenchymal stem cells
|
|
F. Wolf, K. Streckfuss-Bömeke, G. Hasenfuß, K. Guan (Göttingen)
|
|
(P1267)
|
Optimierung von Persistenz und Überleben neonataler Kardiomyozyten nach Transplantation in infarzierte syngene Rattenherzen
|
|
B. Krausgrill, M. Raths, M. Halbach, K. Schenk, J. Hescheler, J. Müller-Ehmsen (Köln)
|
|
(P1268)
|
RGDS-Epitope Presenting Peptide Amphiphile Nanofibers Enhance Therapeutic Potency of Cell-based Strategies in Ischemic Tissue
|
|
J. Tongers, M. J. Webber, M.-A. Renault, J. G. Roncalli, K. Jujo, X. Wu, E. Klyachko, T. Thorne, S. I. Stupp, D. W. Losordo (Hannover; Chicago, US)
|
|
(P1269)
|
Embryonic Stem Cell-Derived Cardiomyocytes: A reliable in vitro model for Pharmacological Screening
|
|
H. Liang, M. Matzkies, H. Schunkert, M. Tang, H. Bonnemeier, J. Hescheler, M. Reppel (Huazhong, CN; Köln, Lübeck, Kiel)
|
|
(P1270)
|
TBX5-Promoter based Magnetic Cell Sorting of ES cell derived cardiomyocytes
|
|
C. Feldmann, W.-M. Franz, R. David (München)
|
|
(P1271)
|
Functional Diversity of Cardiomyocytes Derived from Different Embryonic Stem Cell Lines
|
|
M. Halbach, T. Hannes, M. Khalil, F. Pillekamp, K. Pfannkuche, M. Wolff, X. Doss, K. Brockmeier, A. Sachinidis, J. Müller-Ehmsen, J. Hescheler (Köln)
|
|
(P1272)
|
Maturation of Human Embryonic Stem Cell-Derived Cardiomycytes in Engineered Heart Tissue
|
|
M. Tiburcy, C. Rogge, R. Zweigerdt, T. Böttger, T. Braun, T. Eschenhagen, W.-H. Zimmermann (Göttingen, Hamburg, Bad Nauheim; Singapur, SHP)
|
|
(P1273)
|
G-CSF/AMD3100-induzierte Mobilisierung und Charakterisierung einer Subpopulation hämatopoietischer Progenitorzellen mit hohem therapeutischen Potential bei der myokardialen Regeneration
|
|
N. Langwieser, J. Schwarz, C. Rüder, D. Zohlnhöfer-Momm (Berlin)
|
|
(P1274)
|
The cardiac specific ß-catenin interactor, four-and-a-half LIM-protein 2 (FHL2), promotes differentiaton of cardiac endogenous progenitor cells in vitro
|
|
A. Renger, C. Noack, M.-P. Zafiriou, N. Frey, R. Dietz, M. W. Bergmann, L. Zelarayan (Berlin, Kiel, Hamburg)
|
|
(P1275)
|
Heart-restricted inhibition of beta-catenin signaling via KLF15: effect on cardiac progenitor cells
|
|
C. Noack, M.-P. Zafiriou, A. Renger, R. Dietz, M. W. Bergmann, L. Zelarayan (Berlin, Hamburg)
|